Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma
Clinical trial NCT03415399 · COMPLETED
Trial details
- NCT number
- NCT03415399
- Sponsor
- Eureka Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-09
- Primary completion
- 2020-12-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.